Login/Edit CV
PERSONAL INFORMATION
Full Name: Dr. Ahmed K. Mahdi
Gender: Male Birthdate: 1977 Nationality: Iraq Degree: PhD Academic Title: Lecturer College\Center: College of Medicine
Departement: Pathology and forensic medicine Major: Pathology Specialty: Molecular Pathology Occupation: Lecturer Mother Language: Arabic Other Languages: Arabic, English, Turkish Work email: dr.ahmedkhairallah@nahrainuniv.edu.iq Personal email: dr.ahmedkhairallah@gmail.com
LINKS
Publications
-
Key features of the environment promoting liver cancer in the absence of cirrhosis
M Zaki, A Mahdi, G Patman, A Whitehead, J Maurício, M McCain, D Televantou, S Abou-Beih, E Ramon-Gil, R Watson, C Cox, J Leslie, C Wilson, O Govaere, J Lunec, D Mann, S Nakjang, F Oakley, R Shukla, Q Anstee, D Reeves, 2021
Scientific Reports, 11, (16727)
-
OP-01 Genome wide RNA expression analysis identifies CD44 positive macrophages as promoters of hepatocyte proliferation and the development of NAFLD-HCC
H Zaki, M McCain, A Mahdi, J Mauricio, C Wilson, G Patman, A Whitehead, J Lunec, R Shukla, Q Anstee, D Tiniakos4, F Oakley, 2019
EASL HCC summit 2019
-
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma
C Wu, A Esfandiari, Y Ho, N Wang, A Mahdi, E Aptullahoglu, P Lovat, J Lunec, 2018
British journal of cancer, 118, (4), 495-508 -
Liquid Biopsy-A New Prospect.
A Mahdi, 2018
Iraqi Journal of Medical Sciences, 16, (4) -
What drives development of HCC in non-cirrhotic NAFLD?
A Mahdi, M Zaki, J Lunec, Q Anstee, D Tiniakos, R Shukla, F Oakley, S Cockell, H Reeves, 2018
Journal of Hepatology, 68, S49 -
Molecular pathology: the roles of P53 in the oxidative stress and DNA damage responses in chronic liver disease and hepatocellular carcinoma
A Mahdi, 2018
Newcastle University
-
Abstract P3-07-21: Cytotoxic potential of the RG7388 MDM2-p53 binding antagonist and the GSK2830371 WIP1 inhibitor on MX-1 and MCF-7 human breast cancer cells
V Manoharan, J Lunec, A Esfandiari, A Mahdi, C Wu, M Zanjirband, E Karunanayake, K Tennekoon, S Silva, 2017
Cancer Research, 77, (4 Supplement), P3-07-21-P3-07-21 -
Lipogranulomas, neutrophils and the progression of NAFLD to NASH and HCC
J Mauricio, A Mahdi, J Lunec, G Patman, A Whitehead, D Tiniakos, Q Anstee, F Oakley, D Mann, C Wilson, H Reeves, 2017
HEPATOLOGY, 66, 987A-988A -
MDM2 inhibition for non-genotoxic activation of TP53-a novel strategy for the treatment of hepatocellular carcinoma (HCC)
A Mahdi, H Thomas, S Wedge, R Shukla, H Reeves, J Lunec, 2017
HEPATOLOGY, 66, 369A-369A -
Inhibition of WIP1/PPM1D phosphatase by GSK2830371 potentiates the growth inhibitory and cytotoxic activity of MDM2 antagonists (nutlin-3, RG7388 and HDM201) in cutaneous …
C Wu, A Esfandiari, Y Ho, C Shepherd, A Mahdi, E Aptullahoglu, J Chang, P Lovat, J Lunec, 2017
Cancer Research, 77, (13 Supplement), 2151-2151 -
Cytotoxic potential of the RG7388 MDM2-p53 binding antagonist and the GSK2830371 WIP1 inhibitor on MX-1 and MCF-7 human breast cancer cells
V Manoharan, J Lunec, A Esfandiari, A Mahdi, C Wu, M Zanjirband, E Karunanayake, K Tennekoon, S Silva, 2017
CANCER RESEARCH, 77
-
MDM2 antagonists− a therapeutic approach for patients with hepatocellular carcinoma?
A Mahdi, J Lunec, H Reeves, 2016
European Journal of Cancer, 61, S44
-
PCNA Expression in cagA Strain H. pylori Gastritis: Immunohistochemical and Insitu Hybridization Study.
T Ali, A Mahdi, H Ali, H Hassan, 2012
Iraqi Journal of Medical Sciences, 10, (2)
-
Iraqi JMS
T Ali, A Mahdi, H Ali, H Hassan, 2000
IRAQI JOURNAL OF MEDICAL SCIENCES, 160
1458 Profile visits
-
Profile last updated on: 2021-12-27 15:42:14
Copyright Al-Nahrain University ©2024
Designed by Dr. Rasool Hisham Al-Saadi - Electronic Computer Center
Technical support email: cv@nahrainuniv.edu.iq
Designed by Dr. Rasool Hisham Al-Saadi - Electronic Computer Center
Technical support email: cv@nahrainuniv.edu.iq
Visits: 24992
fetch time:0.321 s